Pay in 4 interest-free payments of $6.74 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Frequently Asked Questions In Phase 3 trials, retatrutide achieved 28.328.7% average weight loss versus tirzepatide's 22.5% a meaningful 56 percentage point difference
Some patients may urinate more frequently, experience discomfort, and urine may appear foamy, bubbly, or cloudy
People trying to maintain their weight
Consider your goals, too
This is supported by the companys focus on expanding its MC4R franchise into adjacent areas, such as acquired hypothalamic obesity to drive growth [59]
US$ 29.15
US$ 24.56
US$ 22.39
US$ 27.30
